ReviewCancers2023

Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy.

Maida Živalj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.